Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial.
about
Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer.Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy.
P2860
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serum thymidine kinase activit ...... cer within a randomized trial.
@ast
Serum thymidine kinase activit ...... cer within a randomized trial.
@en
Serum thymidine kinase activit ...... cer within a randomized trial.
@nl
type
label
Serum thymidine kinase activit ...... cer within a randomized trial.
@ast
Serum thymidine kinase activit ...... cer within a randomized trial.
@en
Serum thymidine kinase activit ...... cer within a randomized trial.
@nl
prefLabel
Serum thymidine kinase activit ...... cer within a randomized trial.
@ast
Serum thymidine kinase activit ...... cer within a randomized trial.
@en
Serum thymidine kinase activit ...... cer within a randomized trial.
@nl
P2093
P2860
P50
P1476
Serum thymidine kinase activit ...... ncer within a randomized trial
@en
P2093
H Johansson
J S Gronowitz
L Carlsson
M Söderberg
T Hatschek
P2860
P2888
P304
P356
10.1007/S10549-013-2579-X
P407
P577
2013-06-05T00:00:00Z
P6179
1046638650